William Blair started coverage on shares of Elanco Animal Health (NASDAQ:ELAN) in a research note issued to investors on Monday, The Fly reports. The firm set a “market perform” rating on the stock.

Several other analysts also recently weighed in on the stock. BMO Capital Markets decreased their price target on shares of Elanco Animal Health from $32.00 to $1.13 and set a “market perform” rating for the company in a research note on Wednesday, December 19th. They noted that the move was a valuation call. Argus initiated coverage on shares of Elanco Animal Health in a research note on Tuesday, January 15th. They set a “buy” rating and a $37.00 price target for the company. Cowen initiated coverage on shares of Elanco Animal Health in a research note on Monday, October 15th. They set an “outperform” rating for the company. Morgan Stanley initiated coverage on shares of Elanco Animal Health in a research note on Monday, October 15th. They set an “equal weight” rating and a $35.00 price target for the company. Finally, Bank of America initiated coverage on shares of Elanco Animal Health in a research note on Monday, October 15th. They set a “neutral” rating and a $34.00 price target for the company. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $31.10.

Shares of Elanco Animal Health stock traded up $0.02 on Monday, hitting $29.71. 9,173,400 shares of the company traded hands, compared to its average volume of 2,629,161. Elanco Animal Health has a 52 week low of $28.00 and a 52 week high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last posted its quarterly earnings results on Wednesday, February 6th. The company reported $0.29 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.03. The company had revenue of $799.30 million for the quarter, compared to the consensus estimate of $804.07 million. During the same period in the prior year, the firm posted $0.12 EPS. The business’s revenue was up 6.0% on a year-over-year basis.

Large investors have recently modified their holdings of the stock. Focused Wealth Management Inc bought a new position in Elanco Animal Health in the fourth quarter worth approximately $32,000. First Hawaiian Bank bought a new position in Elanco Animal Health in the fourth quarter worth approximately $35,000. Public Employees Retirement Association of Colorado bought a new position in Elanco Animal Health in the fourth quarter worth approximately $83,000. Tower Research Capital LLC TRC bought a new position in Elanco Animal Health in the third quarter worth approximately $224,000. Finally, United Services Automobile Association bought a new position in Elanco Animal Health in the third quarter worth approximately $234,000.

About Elanco Animal Health

There is no company description available for Elanco Animal Health Inc

See Also: What is the downside to momentum investing?

The Fly

Analyst Recommendations for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.